Related Experiment Video
Updated: Aug 23, 2026

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum
Published on: January 26, 2024
Opioid peptides in cancer
1Department of Medicinal Chemistry, Medical University of Lodz, Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.
Abstract:
Opioid and somatostatin systems are two main inhibitory systems in mammals implicated in a variety of processes from hormone secretion to the modulation of cell proliferation. Opioids and opioid receptors were found in a great diversity of primary human tumors and in various cancer cell lines. A new area of interest that has developed since the early 1980s has been concerned with the role of endogenous opioid systems in the growth of normal and abnormal tissues and cells. This review presents recent developments on the identification of opioid ligands and receptors in different types of human neoplasia. It also deals with the mechanisms of opioid peptide action in carcinoma and the involvement of opioids in the regulation of tumor growth.
Insights
This review explores how opioid systems influence cancer growth. Researchers identified opioid ligands and receptors in human tumors, suggesting their role in regulating neoplasia.
Area of Science:
- Endocrinology
- Oncology
- Neuroscience
Background:
- Opioid and somatostatin systems are key mammalian inhibitory pathways regulating hormone secretion and cell proliferation.
- Opioids and their receptors are present in numerous human tumors and cancer cell lines.
- Research since the 1980s investigates the role of endogenous opioid systems in normal and abnormal tissue growth.
Purpose of the Study:
- To review recent findings on opioid ligands and receptors in human neoplasia.
- To examine the mechanisms of opioid peptide action in carcinoma.
- To discuss the involvement of opioids in tumor growth regulation.
Main Methods:
- Literature review of studies published since the early 1980s.
- Analysis of research identifying opioid ligands and receptors in various human cancers.
- Synthesis of data on opioid peptide mechanisms and tumor growth regulation.
Main Results:
- Opioid ligands and receptors are widely identified across diverse primary human tumors and cancer cell lines.
- Endogenous opioid systems play a significant role in the growth of both normal and abnormal tissues.
- Evidence suggests opioids are involved in the regulation of tumor progression and development.
Conclusions:
- Opioid systems represent a critical area of study in oncology.
- Understanding opioid involvement in cancer could lead to novel therapeutic strategies.
- Further research into opioid peptide mechanisms in carcinoma is warranted.
Related Concept Videos
Opioid Receptors: Overview
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Analgesia and Pain Management
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
